Back to Journals » OncoTargets and Therapy » Volume 8

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum]

Total article views   HTML views PDF downloads Totals
8,143 Dovepress* 7,771+ 1,566 9,337
PubMed Central* 372 136 508
Totals 8,143 1,702 9,845
*Since 9 March 2015
+Since July 2016

View citations on PubMed Central and Google Scholar